Screener
Summit Therapeutics SMMT Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Summit Therapeutics’s 10-Q, filed August 6, 2024. Open the filing →
- Filed
- Aug 6, 2024
- Fiscal quarter
- Q2 FY2024
- Calendar quarter
- Q2 2024
- Accession
- 0001599298-24-000117
FAQ
- What is Summit Therapeutics's net margin?
- Summit Therapeutics (SMMT) reported net margin of -271,685% in Q2 2023.
- How has Summit Therapeutics's net margin changed year-over-year?
- Summit Therapeutics's net margin decreased by 6446.7% year-over-year, from -4,149.9% to -271,685%.
- What is the long-term trend for Summit Therapeutics's net margin?
- Over 2 years (2020 to 2022), Summit Therapeutics's net margin has grown at a 35.0% compound annual growth rate (CAGR), from -6,127.6% to -11,174.8%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Summit Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude